However, CD27+Ly6C− and CD27+Ly6C+ γδ T cells within the tumor microenvironment expressed the same levels of CD160, NKG2A, NKp46, and CD44, with NKG2A expression in KP tumors being an exception. The gene discussed is KLRC1; the disease is keratosis pilaris.